Tofflon
a lyophilizer leader with roughly 60% of China's mid-to-high-end market, now building 10–15,000 L stainless bioreactors with PAT sensors; it reported about 5.23 billion yuan of 2025 revenue and leads an MIIT high-performance-bioreactor project (30 IP filings, 5 patents).
- Country
- China
- Ticker
- SHE: 300171
FDA GMP
ISO 9001
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| analytics-pat | ✓ | ✓ | — | ✓ |
| fill-finish-packaging | ✓ | ✓ | — | ✓ |
| therapeutics-platforms | ✓ | ✓ | — | ✓ |
| upstream-bioreactors | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsamoa-chinaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Aseptic filling lines | fill-finish-packaging | Low | → |
| Bioprocess analytics & PAT (process analytical technology) | analytics-pat | Low | → |
| Fill-finish & aseptic biomanufacturing | therapeutics-platforms | Low | → |
| Lyophilizers and freeze dryers | fill-finish-packaging | Low | → |
| Single-use bag bioreactors (50L-2000L) | upstream-bioreactors | Low | → |
| Solid-state fermentation bioreactors | upstream-bioreactors | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.